EE400 Cost-Effectiveness of Cannabidiol (CBD) for the Treatment of Seizures in Patients with Treatment-Resistant Lennox-Gastaut Syndrome or Dravet Syndrome in the Netherlands
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.666
https://www.valueinhealthjournal.com/article/S1098-3015(23)03796-8/fulltext
Title :
EE400 Cost-Effectiveness of Cannabidiol (CBD) for the Treatment of Seizures in Patients with Treatment-Resistant Lennox-Gastaut Syndrome or Dravet Syndrome in the Netherlands
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03796-8&doi=10.1016/j.jval.2023.09.666
First page :
Section Title :
Open access? :
No
Section Order :
10149